Lv01
0 积分 2024-08-20 加入
KEAP1 and STK11/LKB1 alterations enhance vulnerability to ATR inhibition in KRAS mutant non-small cell lung cancer
1小时前
已完结
Genomic profiling and prognostic factors of leptomeningeal metastasis in EGFR-mutant NSCLC after resistant to third-generation EGFR-tyrosine kinase inhibitors
1小时前
已完结
Prevalence of osimertinib-induced cardiotoxicity in non-small cell lung cancer patients: a systematic review and meta-analysis
1小时前
待确认
Personalized care for patients with EGFR-mutant nonsmall cell lung cancer: Navigating early to advanced disease management
1小时前
已完结
Comprehensive first-in-human phase I/II study of FHND-9041 in patients with EGFR-mutated advanced non-small cell lung cancer
1小时前
已完结
KRAS Mutation Status in NSCLC: Distribution across Occupational Categories
17天前
已关闭
KRAS Mutation Status in NSCLC: Distribution across Occupational Categories
20天前
已关闭
ROS1 fusion-positive non-small cell lung cancer—repotrectinib as a new treatment option
20天前
已完结
Calcium folinate rescue therapy for severe myelosuppression induced by pemetrexed
26天前
已完结
Current insights and barriers in FGFR-mediated signaling in lung cancer
1个月前
已完结
皖公网安备34019202002308
